FIELD: medicine, experimental medicine.
SUBSTANCE: one should perform sampling of 60-70% against the volume of circulating blood in laboratory animals (rodents) for 2-3 h fractionally, 2-5 times.
EFFECT: increased number of ways for modeling encephalopathy.
3 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR CONTROLLING ERYTHROPOIESIS DISORDERS IN EXPERIMENTAL ENCEPHALOPATHY CASES | 2005 |
|
RU2302664C2 |
METHOD FOR CORRECTING AFFECTED ERYTHROPOIESIS AT EXPERIMENTAL HYPOXIA | 2005 |
|
RU2285300C1 |
METHOD FOR CARRYING OUT EXPERIMENTAL ENCEPHALOPATHY THERAPY | 2004 |
|
RU2284060C1 |
METHOD FOR MODELING HYPOXIC ENCEPHALOPATHY | 2003 |
|
RU2253152C2 |
METHOD FOR MODELING POSTHYPOXIC ENCEPHALOPATHY AND ENCEPHALOPATHY-ASSOCIATED DISORDERS IN BLOOD SYSTEM | 2003 |
|
RU2240604C1 |
MEDICATION POSSESSING HAEMOSTIMULATING, ANTIMUTAGENIC, ANTITUMOUR, CEREBROPROTECTIVE, ANTIHYPOXIC, NOOTROPIC, ANXIOLYTIC AND ANTINEUROTIC ACTION | 2010 |
|
RU2438691C1 |
METHOD OF GRANULOCYTOPENIA-STIMULATING EFFECT EVALUATION FOR PHARMACOLOGICAL SUBSTANCES | 2006 |
|
RU2332667C1 |
METHOD FOR STUDYING HEMOPOIESIS WITH INDIVIDUAL HIGHER NERVOUS ACTIVITY SPECIFIC BEING TAKEN INTO ACCOUNT | 2006 |
|
RU2317541C1 |
HAEMOSTIMULATING AGENT | 2013 |
|
RU2535021C1 |
ANABOLIC AGENT | 2008 |
|
RU2378007C1 |
Authors
Dates
2005-07-27—Published
2003-11-17—Filed